Pfizer offer for AZ sends tremors through U.K. real estate market; Bayer still looking to boost animal health;

@FiercePharma: Cancer-drug market zooms toward $100B, thanks to costly targeted therapies. Article | Follow @FiercePharma

@TracyStaton: Convicted U.S. soldier blames Pfizer's controversial stop-smoking drug Chantix for inexplicable murder. Story via McClatchy | Follow @TracyStaton

@EricPFierce: CEO says Teva will close at least 11 plants, 15% of its network, and 16 more are being evaluated. Story | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: Sanofi's Shan5 overcomes manufacturing setback to score thumbs up from WHO. More from FierceVaccines | Follow @CarlyHFierce

> AstraZeneca ($AZN) CEO Pascal Soriot says that Pfizer's ($PFE) proposed takeover of his company has employees asking whether they should buy homes in Cambridge where the company is moving its key R&D operations. Story

> German healthcare company Fresenius wants the market to know that it has nothing more than small to medium-sized M&A targets on its list; no major deals like some competitors. Story

> AstraZeneca ($AZN) has gotten FDA approval for Epanova capsules, a pure, free fatty acid form of omega-3 for treating adults with extremely high levels of triglycerides in their blood. Release

> Sanofi ($SNY) last year transferred production or packaging of 22 drugs to its Zentiva factory in Romania. Report

> Bayer CEO Marjin Dekkers said that after it closes on the $14.2 billion deal to buy Merck's ($MRK) consumer health business, the merged company will be headquartered at Bayer's offices in Whippany, NJ. Story

> Bayer, which did not include its animal health unit in its deal for Merck's ($MRK) OTC operations as sources suggested it would, says it will look to buy assets to boost the animal health biz. Story

Medical Device News

@FierceMedDev: Mindray Medical revenue jumps up by 9% in Q1. More | Follow @FierceMedDev

@VarunSaxena2: Apple on medical tech hiring spree, a possible hint of iWatch plans. Story | Follow @VarunSaxena2

@EmilyWFierce: California high court to decide whether retailers should have defibrillators on hand for stricken customers. Article | Follow @EmilyWFierce

@MichaelGFierce: Icon's Verisome-delivered cataract inflammation treatment enters PhIII. Release | Follow @MichaelGFierce

> Report: Covidien snaps up BioHarness-maker Zephyr Technology. Story

> Boston Scientific joins Optum Labs as the company's first medical device partner. More

> Abbott might cut back on drugs, putting faith in med tech growth. News

Biotech News

@FierceBiotech: AstraZeneca promises investors a magnificent future--without Pfizer. Story | Follow @FierceBiotech

@JohnCFierce: Some of the new OKs at Merck won't amount to much, some will. Collectively, though, it's a breakthrough. Great to see. | Follow @JohnCFierce

@DamianFierce: Breakthrough melanoma prospect MK-3475 has an FDA decision date set for Oct. 28. Release | Follow @DamianFierce

@EmilyMFierce: Hormone could be key to reversing the aging process. More | Follow @EmilyMFierce

> Loxo lands $24M venture round and a CSO for cancer drug research. Story

> Merck pays $1B to buy into Bayer's cardio future. Article

> AstraZeneca promises investors a magnificent future--without Pfizer. Report

Biotech Research News

> UCSF, Stanford and Johns Hopkins join FDA partnership to speed drug development. More

> Fast-acting antidepressant shows continued relief in animals. Story

> Technique aims to more accurately test pharmaceuticals. Item

> Harvard's bone marrow-on-a-chip could replace animal drug testing. Article

> Novavax, U. of Maryland report positive preclinical results for MERS vaccine. More

Pharma Manufacturing News

> Sanofi's Shantha Biotechnics gets manufacturing issues resolved. News

> Caraco plant in Detroit being shut down by Sun Pharma. Article

> FDA smacks Mexican facility that makes scorpion antivenom for U.S. Story

> Italian mafia at center of network that stole vials of Roche's Herceptin. Report

> Teva whacking 11 plants for sure, another 16 being evaluated. More

And Finally... Synthetic Genomics of La Jolla, CA, has a deal with a subsidiary of United Therapeutics Corporation to grow pigs with "humanized pig organs" to be used in human transplants. Release

Suggested Articles

AbbVie has seen blossoming market share for immunology launches Rinvoq and Skyrizi—and it's eyeing Allergan's neurology biz for a boost, too.

While Novo's Rybelsus launch has slowed due to the pandemic, another version of the med, Ozempic posted strong sales.

AZ sold Atacand and Atacand Plus rights in about 70 countries to Cheplapharm.